FOXP3 and autoimmune disease: The literature data suggest that the expression of the CD127 molecule significantly decreases after the T cells activation, therefore the phenotype of CD4+CD25+CD127− does not coincide strictly with the expression of Foxp3 and does not correspond to the regulatory phenotype, especially in patients with autoimmune diseases (Aerts et al. 2008).